Teladoc Health (TDOC)
(Delayed Data from NYSE)
$9.23 USD
-0.28 (-2.94%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $9.27 +0.04 (0.43%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth F Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$9.23 USD
-0.28 (-2.94%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $9.27 +0.04 (0.43%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth F Momentum A VGM
Zacks News
Strength Seen in Teladoc (TDOC): Can Its 5.7% Jump Turn into More Strength?
by Zacks Equity Research
Teladoc (TDOC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Analysts Estimate Teladoc (TDOC) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Teladoc (TDOC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Teladoc (TDOC) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Teladoc (TDOC) closed at $25.87, marking a +1.09% move from the previous day.
Here's Why You Should Hold Teladoc Health (TDOC) Stock Now
by Zacks Equity Research
Teladoc Health (TDOC) remains well-poised for growth on the back of solid revenues, sustained demand for virtual care services and sufficient cash-generating abilities.
Teladoc (TDOC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Teladoc (TDOC) closed at $25.61, marking a -1.12% move from the previous day.
Is Trending Stock Teladoc Health, Inc. (TDOC) a Buy Now?
by Zacks Equity Research
Teladoc (TDOC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Why Is Teladoc (TDOC) Down 11.7% Since Last Earnings Report?
by Zacks Equity Research
Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Teladoc (TDOC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Teladoc (TDOC) closed at $24.23 in the latest trading session, marking a -1.06% move from the prior day.
Teladoc Health, Inc. (TDOC) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Zacks.com users have recently been watching Teladoc (TDOC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Teladoc (TDOC) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Teladoc (TDOC) closed at $25, marking a +1.54% move from the previous day.
Teladoc (TDOC) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Teladoc (TDOC) closed at $24.62, marking a +1.57% move from the previous day.
Teladoc Health, Inc. (TDOC) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Teladoc (TDOC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Teladoc (TDOC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Teladoc (TDOC) closed at $25.35, marking a -0.59% move from the previous day.
Teladoc's (TDOC) BetterHelp Faces FTC Hurdle, to Pay $7.8M
by Zacks Equity Research
Teladoc's (TDOC) BetterHelp business is expected to continue implementing more comprehensive privacy standards.
Teladoc (TDOC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Teladoc (TDOC) closed at $25.44, marking a -1.7% move from the previous day.
Teladoc Health (TDOC) Down 8.1% Since Q4 Earnings Release
by Zacks Equity Research
Teladoc Health's (TDOC) fourth-quarter results bear the brunt of escalating expenses. Management expects 2023 revenues within $2,550-$2,675 million, way higher than the 2022 figure.
Investors Heavily Search Teladoc Health, Inc. (TDOC): Here is What You Need to Know
by Zacks Equity Research
Teladoc (TDOC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Teladoc (TDOC) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Teladoc (TDOC) delivered earnings and revenue surprises of 14.81% and 0.63%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
5 Critical Earnings Charts
by Tracey Ryniec
It's an important week for earnings as many big pandemic winners are reporting. What do their charts look like?
Teladoc (TDOC) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Teladoc (TDOC) closed at $30.07 in the latest trading session, marking a -1.15% move from the prior day.
Can Teladoc's (TDOC) Q4 Earnings Beat on Growing Visits?
by Zacks Equity Research
The fourth-quarter results of Teladoc Health (TDOC) are likely to reflect a rise in visits and memberships.
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Analysts Estimate NovoCure (NVCR) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
NovoCure (NVCR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Teladoc (TDOC) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Teladoc (TDOC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.